From: Current progress of skin tissue engineering: Seed cells, bioscaffolds, and construction strategies
Source | Potential usages | Autologous possibility | Identified isolation | Unlimited propagation | Pluripotency | Immunogenicity | Tumorigenicity | Legal restriction | Reference |
---|---|---|---|---|---|---|---|---|---|
Skin-derived seed cells | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Keratinocytes | E | • | • | •* |  | • |  |  | [4–6] |
Dermal fibroblasts | D | • | • |  |  | • |  |  | [17, 19] |
Epidermal stem cells | E/D | • |  | • | • | • |  |  | [20, 22, 25, 26] |
Melanocytes | E | • | • |  |  | • |  |  | [30] |
Non-cutaneous cells | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Embryonic stem cells | E/D |  | • | •* | • |  |  | • | [32–34, 36] |
Inducible pluripotent stem cells | E/D | • | • | •* | • | • | • | • | [32, 40–42] |
Mesenchymal stem cells | E/D | • | • |  | • |  |  |  | [47, 48, 50, 51] |
Endothelial cells | D | • | • |  |  | • |  |  | [58, 59] |
Amniotic cells | E/D |  |  |  | • |  |  |  | [63, 64] |